This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Sridhar Mani, MD; Michele Barry, MD; John Concato, MD, MS, MPH

Arch Intern Med. 1993;153(21):2500-2501.

Abstract
Drug-induced agranulocytosis in the outpatient setting is a rare but potentially fatal adverse effect of many classes of medications. Five patients with this disorder presented to Yale-New Haven (Conn) Hospital during 1990 through 1992. Three patients treated with granulocyte-colony stimulating factor and two patients treated with routine care were studied for relevant clinical outcomes. Treatment with granulocyte-colony stimulating factor was associated with a shorter duration of neutropenia and a decreased length of hospital stay, consistent with recent case reports. Despite the high cost of the drug, treatment with granulocyte-colony stimulating factor was found to be cost-effective for patients with uncomplicated drug-induced agranulocytosis.

(Arch Intern Med. 1993;153:2500-2501)

Author Affiliations
From the Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn, and West Haven (Conn) Veterans Affairs Medical Center.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Agranulocytosis Induced by Nonchemotherapy Drugs
Mani
ANN INTERN MED 2008;148:320-320.
FULL TEXT  

Epidemiology and Outcome of Pseudomonas aeruginosa Bacteremia, With Special Emphasis on the Influence of Antibiotic Treatment: Analysis of 189 Episodes
Vidal et al.
Arch Intern Med 1996;156:2121-2126.
ABSTRACT